CN1166381C - Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation - Google Patents

Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation Download PDF

Info

Publication number
CN1166381C
CN1166381C CNB011048409A CN01104840A CN1166381C CN 1166381 C CN1166381 C CN 1166381C CN B011048409 A CNB011048409 A CN B011048409A CN 01104840 A CN01104840 A CN 01104840A CN 1166381 C CN1166381 C CN 1166381C
Authority
CN
China
Prior art keywords
radix
medicine
rhizoma
rheumatoid arthritis
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB011048409A
Other languages
Chinese (zh)
Other versions
CN1311027A (en
Inventor
王希贵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011048409A priority Critical patent/CN1166381C/en
Publication of CN1311027A publication Critical patent/CN1311027A/en
Application granted granted Critical
Publication of CN1166381C publication Critical patent/CN1166381C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a medicine for treating rheumatoid arthritis, osteoarthritis and ankylosing spondylitis, which contains raw materials such as wild ants, herba pyrolae, prepared radix rehmanniae, red ginseng, pubescent angelica roots, pawpaws, notopterygium roots, futokadsura stems, homalomena rhizoma, sinomenium acutum, clematis roots, etc. The medicine not only has a significant therapeutic effect on the three diseases, but also has a fine therapeutic effect on lumbar muscle strain, scapulohumeral periarthritis, hyperosteogeny, lumbocrural pain, numbness of limbs, etc. 15600 clinic patients prove that the medicine has an effective rate of 100% no matter how long a medical history is, has a cure rate of more than 90%, and has no side effect.

Description

A kind of medicine for the treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis
Invention field
The present invention relates to a kind of medicine for the treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis, is the Chinese medicine preparation of treatment rheumatoid arthritis, osteoarthritis and ankylosing spondylitis specifically.
Background technology
Rheumatoid arthritis, osteoarthritis and ankylosing spondylitis etc. belong to rheumatism, mainly involve joint and surrounding soft tissue, comprise muscle, ligament, synovial bursa, fascia etc., are feature with the chronic pain.Rheumatism is how relevant with autoimmune, therefore treats the comparison difficulty.The medicine of this class disease of western medical treatment comprises nonsteroidal antiinflammatory drug and immunosuppressant, as methotrexate, Radix Tripterygii Wilfordii, glucocorticoid etc.But these drug side effectes are many and more serious.
The method of this class disease of Chinese traditional treatment comprises medicine, acupuncture, physical therapy etc., but the outstanding person of curative effect is actually rare.
Summary of the invention
The purpose of this invention is to provide the medicine of a kind of effective treatment rheumatoid arthritis, osteoarthritis and ankylosing spondylitis, is Chinese medicine preparation specifically.This medicine not only has better curative effect to above-mentioned three kinds of diseases, for lumbar muscle strain, scapulohumeral periarthritis, hyperosteogeny, lumbago and skelalgia, numb limbs and tense tendons etc. good curative effect is arranged also.This medicine proves through clinical 15600 routine patients no matter medical history length effective percentage all reaches 100%, and cure rate reaches more than 90%, and is without any side effects.
Medicine of the present invention is formed (by weight) by following raw material:
Wild ant 55-65 Herba Pyrolae 28-32 Radix Rehmanniae Preparata 28-30
Radix Ginseng Rubra 38-41 Radix Angelicae Pubescentis 28-32 Fructus Chaenomelis 38-40
Rhizoma Et Radix Notopterygii 20 Caulis Piperis Kadsurae 55-65 Rhizoma Homalomenae 28-30
Radix Stephaniae Tetrandrae 18-20 Radix Clematidis 28-30 Radix Glycyrrhizae 15-25
The optimum weight proportioning of above-mentioned raw materials is:
Wild ant 60 Herba Pyrolaes 30 Radix Rehmanniae Preparata 30
Radix Ginseng Rubra 40 Radix Angelicae Pubescentiss 30 Fructus Chaenomeliss 40
Rhizoma Et Radix Notopterygii 20 Caulis Piperis Kadsuraes 60 Rhizoma Homalomenaes 30
Radix Stephaniae Tetrandrae 20 Radix Clematidis 30 Radix Glycyrrhizaes 20
The method for preparing medicine of the present invention is: above-mentioned raw materials is ground into fine powder, reinstalls in the capsule.
Certainly, above-mentioned raw materials can be made any dosage form that is suitable for using clinically, as powder, tablet, pill, oral liquid etc.
Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis belong to the scope of arthromyodynia in the traditional Chinese medical science, and its cause of disease mostly is and is affected by the cold, damp, and pathogenesis is that blockage of meridian, QI-blood circulation are not smooth, thereby causes joint joint stuffiness, apathy or swelling.Medicine of the present invention forms by selected medical material prescription, has the effect of eliminating dampness and dredging channels, expelling wind and cold and tonic Liver and kidney.Wherein wild ant, Radix Angelicae Pubescentis, Radix Clematidis, Radix Stephaniae Tetrandrae etc. have resistance to compression, analgesia and immunoregulation effect through the modern medicine proof.
The inventor treats 15600 men and women patients (anemia of pregnant woman, the hyperpietic's forbidding of holding concurrently) altogether with medicine of the present invention, 15 years old-77 years old age, course of disease half a year-40 year, comprise patients such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, lumbar muscle strain, scapulohumeral periarthritis, lumbago and skelalgia, hyperosteogeny, numb limbs and tense tendons, the state of an illness from the arthralgia to the joint deformity, the forfeiture self care ability do not wait.Therapeutic Method is the capsule administration of adopting medicine of the present invention to make, day clothes 2 times, and each 2-3 grain first 2-3 month course of treatment, is interrupted later on and keeps treatment.Patient's symptom of 100% is alleviated as a result, and patient's symptom of nearly 91% is eliminated, and follows the tracks of to follow up a case by regular visits to and do not have recurrence.
Clinical case
Lee * *, woman, 45 years old, the peasant suffered from rheumatoid 3 years, and the nearly articulations digitorum manus swelling distortion in many places is arranged, the rheumatoid factor positive, both hands active receiving obstacle, pain is obvious, can't take care of oneself, through taking medicine of the present invention after three months, pain is eliminated, two hand curl more freely, it is normal that function of joint is recovered substantially.The back interruption is kept and is taken this medicine, can participate in unskilled labour.
Embodiment
Below in conjunction with embodiment the present invention is described.
Embodiment
Wild ant 60g Herba Pyrolae 30g Radix Rehmanniae Preparata 30g
Radix Ginseng Rubra 40g Radix Angelicae Pubescentis 30g Fructus Chaenomelis 40g
Rhizoma Et Radix Notopterygii 20g Caulis Piperis Kadsurae 60g Rhizoma Homalomenae 30g
Radix Stephaniae Tetrandrae 20g Radix Clematidis 30g Radix Glycyrrhizae 20g
Above-mentioned raw materials is ground into fine powder, reinstalls in the capsule, every capsules contains medicated powder 1 gram.

Claims (3)

1, a kind of medicine for the treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis, it is made up of following raw material by weight:
Wild ant 55-65 Herba Pyrolae 28-32 Radix Rehmanniae Preparata 28-30
Radix Ginseng Rubra 38-41 Radix Angelicae Pubescentis 28-32 Fructus Chaenomelis 38-40
Rhizoma Et Radix Notopterygii 20 Caulis Piperis Kadsurae 55-65 Rhizoma Homalomenae 28-30
Radix Stephaniae Tetrandrae 18-20 Radix Clematidis 28-30 Radix Glycyrrhizae 15-25.
2, the medicine of claim 1, wherein the weight portion proportioning of each raw material is:
Wild ant 60 Herba Pyrolaes 30 Radix Rehmanniae Preparata 30
Radix Ginseng Rubra 40 Radix Angelicae Pubescentiss 30 Fructus Chaenomeliss 40
Rhizoma Et Radix Notopterygii 20 Caulis Piperis Kadsuraes 60 Rhizoma Homalomenaes 30
Radix Stephaniae Tetrandrae 20 Radix Clematidis 30 Radix Glycyrrhizaes 20.
3, the preparation method of claim 1 or 2 medicine is characterized in that described raw material powder is broken into fine powder, reinstalls in the capsule.
CNB011048409A 2001-02-26 2001-02-26 Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation Expired - Fee Related CN1166381C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011048409A CN1166381C (en) 2001-02-26 2001-02-26 Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011048409A CN1166381C (en) 2001-02-26 2001-02-26 Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation

Publications (2)

Publication Number Publication Date
CN1311027A CN1311027A (en) 2001-09-05
CN1166381C true CN1166381C (en) 2004-09-15

Family

ID=4654044

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011048409A Expired - Fee Related CN1166381C (en) 2001-02-26 2001-02-26 Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation

Country Status (1)

Country Link
CN (1) CN1166381C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301729C (en) * 2003-10-21 2007-02-28 中国人民解放军总医院 Medicine for treating tetanic rachitis and its prepn process
CN101525391B (en) * 2009-03-31 2011-05-11 武汉大学 Method for extracting amylase from liquorice and application thereof

Also Published As

Publication number Publication date
CN1311027A (en) 2001-09-05

Similar Documents

Publication Publication Date Title
CN100355450C (en) Qinchuan Tongbi tablet
CN101590184B (en) Traditional Chinese medicine combination for treating gout and preparation method thereof
CN100556427C (en) The medicine of treatment rheumatism, rheumatoid arthritis
CN101002873B (en) Medicine for treating recurrent gout, and its preparing method
CN1289114C (en) Arthralgia pain treating bolus and its prepn
CN101745047A (en) Chinese medicinal composition for treating gout disease and preparation method thereof
CN101912536B (en) Medicinal composition for treating rheumatism and rheumatoid disease
CN1060391C (en) Traditional Chinese medicine for treating gynecological tumour
CN103495042A (en) Traditional Chinese medicine composition for treating migraine
CN1166381C (en) Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation
CN1389255A (en) Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis
CN101181389B (en) Medicine for treating rheumatoid arthritis
CN102178759A (en) Traditional Chinese medicine composition for treating rheumatism and preparation method of composition
CN101024029B (en) Medicine for treating bony arthritis, rheumatism arthritis
CN101590166A (en) A kind of Chinese medicine composition that is used for the treatment of gout and preparation method thereof
CN100408048C (en) Capsule for treating rheumatism and rheumatoid diseases and scapulohumeral periarthritis and preparation method thereof
CN1083269C (en) Chinese herbal medicine for treating hysteromyoma and breast fibrosarcoma and its prepn. method
CN1190215C (en) Chinese medicine for treating rheumatism
CN1381250A (en) Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis
CN1325103C (en) Tendon and bone strengthening capsule
CN1057001C (en) Chinese medicine capsule for rheumatoid disease
CN1422639A (en) Dral medicine for treating rheumatism and atrophic diseases
CN101361882B (en) Chinese medicine formulation for treating rheumatic osteoarthropathy
CN105641586A (en) Fengtongning preparation and preparation method thereof
CN1171608C (en) Capsule for treating rheumatism, rheumatoid archritis

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee